RS Research

company

About

RS Research is a pharmaceutical company developing next generation of nanomedicines based on an innovative drug delivery platform.

  • Istanbul,Istanbul,Turkey
  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$12M
Industries
Biotechnology,Pharmaceutical
Founded date
Mar 5, 2015
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
RS Araştırma Eğitim Danışmanlık İlaç Sanayi Ticaret A.Ş.

RS Research is a clinical-stage biotechnology start-up developing novel nanomedicines. We have discovered a novel drug delivery platform with which we currently have development programs in various preclinical and clinical stages for therapies to treat patients fighting cancer.
Our nanocarrier platform (Sagitta®) is highly tunable with a plug & play approach, allowing rapid development of targeted nanomedicines with superior performance aiming multiple indications.
Along with moving our own candidates toward clinic, we provide preclinical services to industrial and academic partners. We have specific expertise in biosimilar characterization as well as in vivo experiment design and implementation. Our GMP certified production facility is the first cytotoxic-capable clinical batch-size contract organization for such services in the region.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$12M €2M
RS Research has raised a total of $12M €2M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 15, 2021 Series A $12M 3 Gen Pharmaceuticals Detail
Jan 10, 2018 Convertable Note €0.90M 1 ACT Venture Partners Detail
Apr 21, 2017 Seed €1.10M 1 ACT Venture Partners Detail

Investors

Number of Lead Investors
Number of Investors
3
4
RS Research is funded by 4 investors. Gen Pharmaceuticals and ACT Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Gen Pharmaceuticals Yes Series A
ACT Venture Partners Yes Convertable Note
Eczacıbasi Momentum Series A
İstanbul Portföy Yönetimi Series A

Employee Profiles

Number of Employee Profiles
3
RS Research has 3 current employee profiles, including Board observer Gokhan Guner
Board observer
Board member
Board member